288 related articles for article (PubMed ID: 26172508)
1. MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.
Jimenez L; Sharma VP; Condeelis J; Harris T; Ow TJ; Prystowsky MB; Childs G; Segall JE
Arch Pathol Lab Med; 2015 Nov; 139(11):1349-61. PubMed ID: 26172508
[TBL] [Abstract][Full Text] [Related]
2. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
Clark ES; Whigham AS; Yarbrough WG; Weaver AM
Cancer Res; 2007 May; 67(9):4227-35. PubMed ID: 17483334
[TBL] [Abstract][Full Text] [Related]
3. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
[TBL] [Abstract][Full Text] [Related]
4. Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop.
Hayes KE; Walk EL; Ammer AG; Kelley LC; Martin KH; Weed SA
Oncogene; 2013 Oct; 32(40):4766-77. PubMed ID: 23146907
[TBL] [Abstract][Full Text] [Related]
5. Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma.
Susuki D; Kimura S; Naganuma S; Tsuchiyama K; Tanaka T; Kitamura N; Fujieda S; Itoh H
Cancer Sci; 2011 Dec; 102(12):2164-71. PubMed ID: 21899661
[TBL] [Abstract][Full Text] [Related]
6. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.
Artym VV; Zhang Y; Seillier-Moiseiwitsch F; Yamada KM; Mueller SC
Cancer Res; 2006 Mar; 66(6):3034-43. PubMed ID: 16540652
[TBL] [Abstract][Full Text] [Related]
7. Impact of flavonoids on matrix metalloproteinase secretion and invadopodia formation in highly invasive A431-III cancer cells.
Lin YC; Tsai PH; Lin CY; Cheng CH; Lin TH; Lee KP; Huang KY; Chen SH; Hwang JJ; Kandaswami CC; Lee MT
PLoS One; 2013; 8(8):e71903. PubMed ID: 23991004
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.
Bourguignon LY; Wong G; Shiina M
J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147
[TBL] [Abstract][Full Text] [Related]
9. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
[TBL] [Abstract][Full Text] [Related]
11. miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene.
Liu CJ; Shen WG; Peng SY; Cheng HW; Kao SY; Lin SC; Chang KW
Int J Cancer; 2014 Feb; 134(4):811-21. PubMed ID: 23824713
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
13. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
[TBL] [Abstract][Full Text] [Related]
14. Protease activity at invadopodial focal digestive areas is dependent on NHE1-driven acidic pHe.
Greco MR; Antelmi E; Busco G; Guerra L; Rubino R; Casavola V; Reshkin SJ; Cardone RA
Oncol Rep; 2014 Feb; 31(2):940-6. PubMed ID: 24337203
[TBL] [Abstract][Full Text] [Related]
15. Nanobodies targeting cortactin proline rich, helical and actin binding regions downregulate invadopodium formation and matrix degradation in SCC-61 cancer cells.
Bertier L; Hebbrecht T; Mettepenningen E; De Wit N; Zwaenepoel O; Verhelle A; Gettemans J
Biomed Pharmacother; 2018 Jun; 102():230-241. PubMed ID: 29567535
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
Kinoshita T; Nohata N; Fuse M; Hanazawa T; Kikkawa N; Fujimura L; Watanabe-Takano H; Yamada Y; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
Biochem Biophys Res Commun; 2012 Feb; 418(2):378-83. PubMed ID: 22266319
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC).
Zhang J; Wang Y; Chen X; Zhou Y; Jiang F; Chen J; Wang L; Zhang WF
Oncotarget; 2015 Apr; 6(10):7454-69. PubMed ID: 25762634
[TBL] [Abstract][Full Text] [Related]
18. Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression.
Hwang YS; Xianglan Z; Park KK; Chung WY
Carcinogenesis; 2012 Nov; 33(11):2135-46. PubMed ID: 22859271
[TBL] [Abstract][Full Text] [Related]
19. Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Kim J; Kang SM; Oh SY; Kang SH; Lee I; Hwang JC; Lee HJ; Choi SY; Hong SH
Cell Physiol Biochem; 2018; 50(5):1869-1881. PubMed ID: 30396177
[TBL] [Abstract][Full Text] [Related]
20. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
Arosarena OA; Barr EW; Thorpe R; Yankey H; Tarr JT; Safadi FF
J Cell Physiol; 2018 Jan; 233(1):409-421. PubMed ID: 28295306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
